# Cellectar Biosciences, Inc.: Form 8-K, filed Nov 29, 2023

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: 8-K
- Filed: 2023-11-29
- Accepted by EDGAR: Nov 29, 2023, 16:31 ET
- Period: 2023-11-21
- Accession: 0001104659-23-122057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/tm2331790d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/tm2331790d1_8k.htm

Filed Nov 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-122057. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
